WallStSmart

McCormick & Company Incorporated (MKC-V)vsSRx Health Solutions Inc. (SRXH)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

McCormick & Company Incorporated generates 73129% more annual revenue ($6.84B vs $9.34M). MKC-V leads profitability with a 11.5% profit margin vs 0.0%. MKC-V earns a higher WallStSmart Score of 52/100 (C-).

MKC-V

Buy

52

out of 100

Grade: C-

Growth: 4.7Profit: 6.5Value: 7.3Quality: 5.0

SRXH

Avoid

19

out of 100

Grade: F

Growth: 2.7Profit: 3.0Value: 5.0Quality: 4.0
Piotroski: 2/9Altman Z: -4.74
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

MKC-VSignificantly Overvalued (-44.2%)

Margin of Safety

-44.2%

Fair Value

$49.93

Current Price

$52.86

$2.93 premium

UndervaluedFair: $49.93Overvalued

Intrinsic value data unavailable for SRXH.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MKC-V1 strengths · Avg: 8.0/10
Price/BookValuation
2.5x8/10

Reasonable price relative to book value

SRXH0 strengths · Avg: 0/10

No standout strengths identified

Areas to Watch

MKC-V2 concerns · Avg: 4.0/10
PEG RatioValuation
1.934/10

Expensive relative to growth rate

Revenue GrowthGrowth
2.9%4/10

2.9% revenue growth

SRXH4 concerns · Avg: 3.3/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$36.08M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : MKC-V

The strongest argument for MKC-V centers on Price/Book.

Bull Case : SRXH

SRXH has a balanced fundamental profile.

Bear Case : MKC-V

The primary concerns for MKC-V are PEG Ratio, Revenue Growth.

Bear Case : SRXH

The primary concerns for SRXH are EPS Growth, Market Cap, Return on Equity. Debt-to-equity of 10.99 is elevated, increasing financial risk.

Key Dynamics to Monitor

MKC-V is growing revenue faster at 2.9% — sustainability is the question.

MKC-V generates stronger free cash flow (458M), providing more financial flexibility.

Monitor PACKAGED FOODS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

MKC-V scores higher overall (52/100 vs 19/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

McCormick & Company Incorporated

CONSUMER DEFENSIVE · PACKAGED FOODS · USA

McCormick & Company is an American multinational food company that manufactures, markets, and distributes spices, seasoning mixes, condiments, and other flavoring products to retail outlets, food manufacturers, and foodservice businesses.

SRx Health Solutions Inc.

CONSUMER DEFENSIVE · PACKAGED FOODS · USA

SRx Health Solutions Inc. provides healthcare and medical treatment services.

Visit Website →

Want to dig deeper into these stocks?